FDA manufacturing meeting cancelled
Executive Summary
A meeting of the Manufacturing Subcommittee of FDA's Pharmaceutical Science Advisory Committee planned for April 18-19 has been cancelled by the agency. The subcommittee was to have discussed modernized good manufacturing practices for process validation; the chemistry, manufacturing and controls pilot program; and other issues (1"The Pink Sheet" Feb. 27, 2006, In Brief)...
You may also be interested in...
Modernized GMPs
FDA's Manufacturing Subcommittee of its Pharmaceutical Science Advisory Committee will discuss modernized good manufacturing practices for process validation on April 18-19. The subcommittee will also receive updates on International Conference on Harmonization quality guidelines Q8, Q9 and Q10 plus future ICH quality topics. The subcommittee will also discuss FDA's CMC Pilot Program and guidance. The meeting will be held at CDER's advisory committee conference room at 5630 Fishers Lane in Rockville, Md. beginning at 8:30 a.m. on both days...
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Gel
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.
US FDA Expects Joint AdComm Briefing Document, Oncology Chief Says
The combined format is the new default for briefing advisory committee members, US FDA Oncology Center of Excellence Director Pazdur declared.